
About Curia
Curia is a company based in Burlington (United States) by Shawn Kinney. It operates as a Professional Services and Managed Services. Curia offers products and services including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product. Curia operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Burlington, United States
- Founders Shawn Kinney
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website amriglobal.com
- Social LinkedIn X Facebook
- Legal Name Curia Global, Inc.
Products & Services of Curia
Curia offers a comprehensive portfolio of products and services, including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Services for small molecule drug discovery are provided.
Generic active pharmaceutical ingredients are developed and manufactured.
Biologics discovery and manufacturing services are offered comprehensively.
Sterile drug product development services are provided expertly.
People of Curia
269 people are tracked at Curia (100 in leadership, 169 in team).
| Name | Role | Group |
|---|---|---|
Shawn Kinney | Ex-President, Founder | Leadership |
Steve Lichter | President, API | Leadership |
Grant Carr | Vice President, Global R&d Drug Discovery Site Head, Buffalo | Leadership |
Eva Gajate | Operations Director | Leadership |
Mark Wolf | Director, Medicinal Chemistry | Leadership |
Sean Ballou | Senior Director Quality Assurance | Leadership |
Rebecca Alcantara | Director, Global Supplier Quality & Compliance | Leadership |
Geno Worke | Senior Director Of Operations | Leadership |
Kristine Shepherd Cqm/Oe | Director Of Quality | Leadership |
Barb Baldwin | Supply Chain Director | Leadership |
Philip Macnabb | CEO | Leadership |
Jeffrey Stowe | Director Project Engineering | Leadership |
Roberto Salghetti Drioli | EU Quality Operations Director (api, DP And R&d Sites) | Leadership |
Ganesh Kamath | VP Of Finance, Sales Operations And Development | Leadership |
Steven Schneider | Senior Director Generic Sales API | Leadership |
Simonetta Conti | Head Of Regulatory Affairs Italy And France | Leadership |
Michelle Dellefave | Associate Director, IT - Quality Systems | Leadership |
Michel Desbordes | Head Of Production | Leadership |
Faten Shawwa | Site Quality Head | Leadership |
Adam Harshman | Tax Director | Leadership |
249 more people are available in the full profile.
Complete people profiles for Curia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Curia
Curia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gsk.com | 1715 | Brentford, United Kingdom | – | 90,913 | Developer of pharmaceuticals and vaccines for various therapeutic areas | |
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. |
Detailed competitors of Curia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Curia
The website of Curia (amriglobal.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Curia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Curia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Curia
Complete news archive for Curia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Curia
10 companies that operate in the same segment as Curia (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Curia
Curia is headquartered in Burlington, United States. It is registered at Burlington, Vermont, United States.
Curia is involved in providing comprehensive services for drug discovery, development, and manufacturing across small molecules, generic APIs, and biologics. The company operates in the healthcare sector, focusing on pharmaceutical and biopharmaceutical solutions. With a global network of 23 facilities and over 3,500 professionals, Curia supports clients in North America, Europe, and India. Services are tailored to meet complex needs, ensuring flexibility and scalability. Advanced technologies and scientific expertise are utilized to accelerate therapy delivery to patients while maintaining high standards of quality.
Curia's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Curia offers Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Curia operates through Curia Global, Inc..
The website of Curia receives about 681 thousand visits a month.
